Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11802125 Functionalized heterocyclic compounds as antiviral agents

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Samuel Bartlett

Dexter Davis

Joseph D. Panarese

Yat Sun Or

Nathaniel Thomas Kenton

Date of Patent

October 31, 2023

Patent Application Number

17201308

Date Filed

March 15, 2021

Patent Citations

US Patent 7741494 Histone deacetylase inhibitors

US Patent 7232825 Phenylaminopyrimidine derivatives and methods of use

US Patent 7312214 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors

US Patent 7411003 Inhibition of Hepatitis B virus by cyclohexenone compounds from

US Patent 7615569 Inhibitors of ion channels

US Patent 10189846 Hepatitis B antiviral agents

US Patent 10253030 Crystal form, preparation method and intermediate of dihydropyrido ring compound

US Patent 10428070 Hepatitis B antiviral agents

...

Patent Primary Examiner

Niloofar Rahmani

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11802125 Functionalized heterocyclic compounds as antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool